COM:GLENMARKPHARMA
Glenmark Pharmaceuticals
- Stock
Last Close
1,466.40
22/11 08:00
Market Cap
390.66B
Beta: -
Volume Today
352.00K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 6.97B - | 5.94B 14.72% | 10.05B 69.07% | 12.60B 25.42% | 10.67B 15.34% | 12.58B 17.92% | 10.96B 12.87% | 13.82B 26.13% | 14.41B 4.25% | 8.68B 39.74% | -18.99B 318.66% | |
depreciation and amortization | 2.17B - | 2.60B 19.92% | 2.69B 3.52% | 5.77B 114.21% | 3.54B 38.59% | 5.47B 54.36% | 4.17B 23.67% | 4.44B 6.33% | 4.87B 9.73% | 6.11B 25.59% | 5.82B 4.80% | |
deferred income tax | 486.47M - | -2.94B 704.98% | -3.68B - | -9.33B 153.92% | -5.91B 36.70% | -6.23B 5.43% | -7.33B 17.69% | -8.79B 19.96% | ||||
stock based compensation | -4.69M - | 3.08M 165.67% | 90.64M - | 1.07M 98.82% | 30.84M 2,782.24% | 79.37M 157.36% | 79.16M 0.26% | 67.74M 14.43% | 49.62M 26.75% | |||
change in working capital | -2.90B - | -2.67B 7.85% | -6.08B 127.34% | -8.62B 41.76% | 3.09B 135.87% | 1.36B 55.89% | 1.27B 6.80% | -3.86B 403.66% | -5.61B 45.47% | -10.74B 91.44% | -7.97B 25.83% | |
accounts receivables | 444.31M - | -2.93B 758.73% | -1.18B 59.72% | -5.49B 365.86% | -8.49B 54.52% | 9.70B 214.23% | ||||||
inventory | -511.92M - | -3.54B 592.35% | -4.34B 22.42% | -6.14B 41.58% | 1.35B 122.02% | -4.29B 416.86% | 972.56M 122.69% | -1.34B 237.58% | -2.03B 52.02% | -3.75B 84.43% | -5.14B 36.97% | |
accounts payables | 4.49B - | 1.53B 66.02% | 1.60B 5.06% | 847.57M 47.18% | 1.66B 96.10% | -7.34B 541.87% | ||||||
other working capital | -2.39B - | 871.21M 136.47% | -1.74B 299.51% | -2.47B 42.22% | 1.74B 170.29% | 711.44M 59.06% | 1.70B 138.60% | -2.95B 273.55% | 1.07B 136.21% | -167.73M 115.72% | -5.18B 2,989.43% | |
other non cash items | 1.82B - | 1.89B 3.72% | -3.21B 270.27% | -3.18B 1.12% | 2.77B 187.07% | 3.17B 14.42% | 3.40B 7.35% | 3.06B 9.96% | 4.67B 52.67% | 10.93B 133.95% | 27.92B 155.48% | |
net cash provided by operating activities | 8.54B - | 4.82B 43.58% | 3.45B 28.41% | 6.57B 90.64% | 16.48B 150.68% | 13.24B 19.65% | 13.92B 5.15% | 11.31B 18.76% | 11.09B 1.99% | 6.25B 43.59% | -7.65B 222.33% | |
investments in property plant and equipment | -3.77B - | -5.44B 44.51% | -8.90B 63.57% | -7.49B 15.92% | -10.45B 39.56% | -12.37B 18.43% | -9.31B 24.72% | -7.75B 16.82% | -7.90B 1.98% | -6.08B 23.08% | -9.15B 50.53% | |
acquisitions net | 6.22B - | 1.56B 74.91% | 994.33M 36.27% | 112.52M 88.68% | 803.47M 614.07% | 54.52B 6,685.18% | ||||||
purchases of investments | -150M - | -1.61B 973.54% | -29.08M 98.19% | -400.18M 1,276.13% | -60.08M 84.99% | -1.29M 97.85% | ||||||
sales maturities of investments | 85.55M - | 50M 41.55% | -965.25M 2,030.50% | 300M 131.08% | 50M 83.33% | 70.51M 41.02% | ||||||
other investing activites | 85.21M - | 42.38M 50.26% | 101.01M 138.34% | 361.84M 258.22% | 312.97M 13.51% | -772.66M 346.88% | 1.48B 291.36% | 995.22M 32.69% | 4.56B 357.79% | -670K 100.01% | -166.32M 24,723.88% | |
net cash used for investing activites | -3.68B - | -5.40B 46.71% | -8.80B 62.98% | -7.12B 19.07% | -10.13B 42.25% | -6.99B 31.02% | -7.84B 12.09% | -6.75B 13.82% | -3.33B 50.64% | -5.28B 58.57% | 45.44B 959.76% | |
debt repayment | -6.28B - | -6.91B 10.05% | -13.40B 93.95% | -20.95B 56.43% | -8.69B 58.51% | -10.51B 20.84% | -8.38B 20.28% | -17.11B 104.27% | -30.19B 76.47% | -5.13B 83.00% | -31.68B 517.35% | |
common stock issued | 125.01M - | 20.34M 83.73% | 9.35B 45,892.87% | 2.64M 99.97% | 4.44B - | 10.12B - | 12M - | |||||
common stock repurchased | 6.38B - | 9.92B 55.53% | -318.85M - | 16.37B - | ||||||||
dividends paid | -631.91M - | -634.65M 0.43% | -678.53M 6.91% | -678.05M 0.07% | -678.82M 0.11% | -678.81M 0.00% | -685.54M 0.99% | -704.47M 2.76% | -926.95M 31.58% | -1.37B 47.37% | -1.18B 13.80% | |
other financing activites | -576.97M - | -409.15M 29.09% | 11.70B 2,960.80% | 27.06B 131.20% | 4.69B 82.68% | -318.85M 106.80% | 4.61B 1,547.24% | 13.40B 190.29% | -573.88M 104.28% | 5.72B 1,097.37% | -344.62M 106.02% | |
net cash used provided by financing activities | -980.16M - | 1.99B 303.26% | 6.99B 250.66% | 5.43B 22.25% | -4.68B 186.26% | -7.39B 57.68% | -4.45B 39.81% | -4.42B 0.65% | -5.20B 17.82% | -774.56M 85.12% | -33.89B 4,275.83% | |
effect of forex changes on cash | -1.98B - | -1.72B 13.17% | -698.87M 59.35% | -2.89B 313.52% | 107.80M 103.73% | -1.84B 1,802.42% | 97.64M 105.32% | 136.22M 39.51% | 175.50M 28.84% | 123.80M 29.46% | 176.79M 42.80% | |
net change in cash | 1.90B - | -310.64M 116.38% | 933.86M 400.62% | 1.99B 113.35% | 1.77B 11.17% | -2.97B 267.85% | 1.74B 158.57% | 278.20M 84.01% | 2.72B 879.26% | 325M 88.07% | 1.90B 483.88% | |
cash at beginning of period | 6.05B - | 7.95B 31.33% | 7.64B 3.91% | 8.57B 12.23% | 10.56B 23.25% | 12.33B 16.75% | 9.36B 24.09% | 11.10B 18.58% | 11.38B 2.51% | 14.11B 23.94% | 14.70B 4.19% | |
cash at end of period | 7.95B - | 7.64B 3.91% | 8.57B 12.23% | 10.56B 23.25% | 12.33B 16.75% | 9.36B 24.09% | 11.10B 18.58% | 11.38B 2.51% | 14.11B 23.94% | 14.43B 2.30% | 16.59B 15.00% | |
operating cash flow | 8.54B - | 4.82B 43.58% | 3.45B 28.41% | 6.57B 90.64% | 16.48B 150.68% | 13.24B 19.65% | 13.92B 5.15% | 11.31B 18.76% | 11.09B 1.99% | 6.25B 43.59% | -7.65B 222.33% | |
capital expenditure | -3.77B - | -5.44B 44.51% | -8.90B 63.57% | -7.49B 15.92% | -10.45B 39.56% | -12.37B 18.43% | -9.31B 24.72% | -7.75B 16.82% | -7.90B 1.98% | -6.08B 23.08% | -9.15B 50.53% | |
free cash flow | 4.77B - | -626M 113.12% | -5.45B 771.28% | -910.97M 83.30% | 6.03B 762.39% | 870M 85.58% | 4.61B 429.93% | 3.56B 22.68% | 3.19B 10.64% | 176.29M 94.47% | -16.80B 9,629.43% |
All numbers in (except ratios and percentages)